Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulation
Active rTMS at the LMC for Gulf War Syndrome
N/A
Recruiting
Led By Albert Leung, M.D.
Research Sponsored by Veterans Medical Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-week, 1-month, 2-month, and 3-month
Awards & highlights
Study Summary
This trial will study if using magnetic pulses to stimulate the brain can help relieve headaches and pain related to Gulf War Illness.
Eligible Conditions
- Gulf War Syndrome
- Muscle Pain
- Arthritis
- Headache
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1-week, 1-month, 2-month, and 3-month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-week, 1-month, 2-month, and 3-month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline to post treatment of GWI-related pain and headaches
Change from baseline to post treatment of body pain
Change from baseline to post treatment of fatigue
+8 moreSecondary outcome measures
Change from baseline to post treatment of PTSD symptoms
Change in opioid-based pain medication usage
Explore changes in supraspinal resting state functional connectivity
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active rTMS at the LMCActive Control1 Intervention
Subjects will receive the repetitive Transcranial Magnetic Stimulation (rTMS) study procedure at the left motor cortex (LMC)
Group II: Sham rTMS at the LMCPlacebo Group1 Intervention
Sham rTMS will appear the same as the active, with the same parameters, but will not receive the actual magnetic stimulation to the LMC.
Find a Location
Who is running the clinical trial?
Veterans Medical Research FoundationLead Sponsor
43 Previous Clinical Trials
4,784 Total Patients Enrolled
1 Trials studying Gulf War Syndrome
90 Patients Enrolled for Gulf War Syndrome
United States Department of DefenseFED
861 Previous Clinical Trials
227,044 Total Patients Enrolled
6 Trials studying Gulf War Syndrome
285 Patients Enrolled for Gulf War Syndrome
Albert Leung, M.D.Principal InvestigatorSan Diego Veterans Healthcare System
2 Previous Clinical Trials
130 Total Patients Enrolled
1 Trials studying Gulf War Syndrome
90 Patients Enrolled for Gulf War Syndrome
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of severe memory problems, serious mental illnesses, or very serious medical conditions.Your average daily muscle pain is more than 3 out of 10 on a pain scale.You are currently receiving therapy to help improve your memory or treat post-traumatic stress disorder (PTSD).You experience joint pain in your arms or legs that is rated higher than 3 on a scale of 0 to 10.You have low back pain caused by issues like nerve compression or joint problems in your lower back.You have had a previous head injury.You have chronic tension headaches or cluster headaches.You have had severe headaches at least three times a week for the past three months. The headaches last for more than four hours and have an average intensity greater than three on a scale of 0 to 10.You have other long-lasting nerve pain conditions like Complex Regional Pain Syndrome or Painful Peripheral Neuropathy.You have a history of seizures.I'm sorry, but I need more context or information about the Kansas Criteria for GWI in order to provide you with a simplified explanation.
Research Study Groups:
This trial has the following groups:- Group 1: Active rTMS at the LMC
- Group 2: Sham rTMS at the LMC
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger